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Schistosomiasis is a chronic disease caused by trematode ﬂatworms of the genus Schistosoma; it accounts
for more than 280,000 deaths annually. In this work we investigated the effect of the alkaloidic extract
obtained by acid–base extraction of the dried fruits of Solanum lycocarpum on schistosomiasis. We used
this extract at concentrations of 10, 20, and 40 mg/kg to treat mice infected with Schistosoma mansoni in
different phases of the parasite cycle, and we compared its effect with that of the positive control prazi-
quantel (60 mg/kg). We evaluated the results on the basis of the number of macrophages, eggs, and gran-
ulomas; we also assessed nitric oxide (NO) and interferon-gamma (IFN-c) production. Animals treated
with a daily dose of 10 or 20 mg/kg alkaloidic extract between the 37th and 41st day of infection showed
increased number of macrophages, elevated NO and IFN-c concentrations, and reduced number of eggs
and granulomas in the liver. The alkaloidic extract of S. lycocarpum fruits displayed an immunomodula-
tory effect on mice infected with S. mansoni, so its potential to treat schistosomiasis deserves further
studies.
 2013 Elsevier Inc. Open access under the Elsevier OA license.cell; IFN-c, interferon-gamma; IL, interleukin; M-CSF, macrophage colony-stimulating factor; GM–CSF, granulocyte/
uclear cells; NO, nitric oxide; iNOS, inducible nitric oxide synthase; NF-jB, nuclear factor kappa B; PZQ, praziquantel;
Jr.), jkbastos@fcfrp.usp.br (J.K. Bastos).
evier OA license.
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Schistosomiasis is a chronic disease caused by trematode ﬂat-
worms of the genus Schistosoma; it remains a major neglected pov-
erty-related health problem in many tropical areas (Steinmann
et al., 2006). The morbidity triggered by schistosomiasis seems to
be inﬂuenced by the nature of the induced immune response asso-
ciated with the parasite, the effects of the disease on granuloma
formation, and the pathologies elicited by schistosomiasis in target
organs (Cheever et al., 2000). Praziquantel (PZQ) is used to treat the
main human schistosomiasis, since it can eliminate adult worms
during the chronic phase of the infection (Aragon et al., 2009;
Sayed et al., 2008); oxamniquine is another available drug, but
its use is limited (Ferrari et al., 2003). These drugs display low efﬁ-
cacy during the acute phase of schistosomiasis, and there is no vac-
cine against the disease. Therefore, the search for new and more
effective schistosomicidal drugs is mandatory.
The relationship between disease and immune response in
schistosomiasis has been reported for distinct animal models.
Studies performed during the acute phase of the infection demon-
strated that peripheral-blood mononuclear cells (PBMCs) generate
large quantities of tumor necrosis factor-alpha (TNF-a), interleukin
(IL)-1, and IL-6 (De Jesus et al., 2002). The eggs released during the
natural progression of schistosomiasis produce antigens that prob-
ably induce a stronger helper T cell (Th2) response, which down-
regulates the production and effector function of the pro-
inﬂammatory mediators (Montenegro et al., 1999). Mononuclear
cells generate considerable levels of TNF, IL1, and IL6 via a Th1-
type response during oviposition in the acute phase. The mecha-
nisms involved in the response to acute infection have not been
fully elucidated in murine models yet. A Th1 immune response
to parasite antigen seems to predominate in the acute phase, but
it is replaced by a Th2 immune response upon egg antigen produc-
tion (De Jesus et al., 2002; Pearce and Macdonald, 2002).
Investigations have shown that different animal models in-
fected with Schistosoma mansoni cannot develop an adequate Th2
response to regulate the initial pro-inﬂammatory interleukin pro-
ﬁle associated with acute schistosomiasis (Fallon et al., 2000; Bru-
net et al., 1997). Although Th2 response seems to be crucial in
modulating potentially life-threatening diseases, schistosomiasis
triggers a prolonged Th2 response in its initial phase, which con-
tributes to the development of hepatic ﬁbrosis and chronic mor-
bidity. The main Th2 cytokine responsible for ﬁbrosis is IL-13
(Fallon et al., 2000). Some mediators such as IL-12, TNF-a, nitric
oxide (NO), and interferon-gamma (INF-c) prevent production of
excess IL-13 during S. mansoni infection. Previous works have re-
ported that S. mansoni-infected mice present increased IFN-c con-
centration, which is important for infection control during the
acute and chronic phases of the disease (Pearce and Macdonald,
2002; Hesse et al., 2001; Grzych et al., 1991).
IFN-c directly stimulates phagocytic cells to destroy internal-
ized parasites, mainly through NO generation (Aliberti et al.,
1996). Numerous studies have documented the potent antimicro-
bial and antiparasitic activity of NO on protozoan and metazoan
parasites in deﬁnitive and intermediate hosts (Ascenzi and
Gradon, 2002; James, 1995). NO produced by IFN-c-activated
macrophages generate an antiﬁbrogenic substance inside the
schistosome granuloma, which is considered a major pathway
in the induction of protective immunity against this disease
(James et al., 1998). The immune-modulation detected during
infectious disease may be associated with shifts in the balance
of some cytokine proﬁles. Hence, pathologic cytokine deregula-
tion may affect the expression of various immune responses,
including those that could cause resistance to infection (Powell
and Sonnenfeld, 2006).The search for new active compounds that can modulate the
immune system has prompted investigation of medicinal plants
such as Solanum lycocarpum, which displays activity against S.
mansoni in vitro (Miranda et al., 2012). S. lycocarpum A. St.-Hil
(Solanaceae) is a typical plant species of the Brazilian savanna (cer-
rado), and it gives a fruit that is popularly known as wolf-fruit.
Wolves (Chrysocyon brachyurus) that feed upon this fruit do not
normally develop renal parasitism caused by Dioctophyma renale
(Silva, 2002). These fruits contain two major glycoalkaloids, sola-
margine and solasonine, which bear the aglycone solasodine (Sch-
warz et al., 2007). The S. lycocarpum extract and its glycoalkaloids
possess antifungal (Fewell et al., 1994), antiprotozoan (Hall et al.,
2006), schistosomicidal (Miranda et al., 2012), molluscicidal (Bag-
alwa et al., 2010), and antitumor activities (Cham, 2007).
Considering the promising activities of S. lycocarpum, in this
study we evaluated the immunomodulatory response triggered
by the S. lycocarpum alkaloidic extract during the chronic phase
of experimental S. mansoni infection in vivo. We compared our re-
sults with those achieved using praziquantel (PZQ), the drug that is
currently employed to treat the chronic phase of schistosomiasis.2. Material and methods
2.1. Plant material
The fruits of S. lycocarpum were collected in the city of Cajuru,
State of São Paulo, Brazil. Samples were authenticated by PhD. Mil-
ton Groppo Júnior, and a voucher specimen was deposited at the
Herbarium of the University of São Paulo (USP), São Paulo State,
Brazil (number: SPFR: 11638).
2.2. Extraction of glycoalkaloids
The powdered dried fruits of S. lycocarpum were submitted to
hydrochloric acid (0.2 mol/L) extraction by maceration, overnight.
The extract was ﬁltered and treated with NaOH 6.0 mol/L, to
achieve pH 12.0. After precipitation, the supernatant was removed,
and the precipitate was centrifuged and suspended in ethanol. The
ethanol soluble fraction was concentrated under vacuum and
lyophilized, to yield the alkaloidic extract. This extract was dis-
solved in 0.7% Tween 80 solution and later administered to the test
animals.
2.3. Experimental animals
Swiss female mice weighing 25–30 g were used in this work.
The mice were placed in in plastic cages (ﬁve mice in each cage)
and kept at a temperature of 23 ± 2 C in a 12/12 day/night sche-
dule. Commercial rodent diet and water were available ad libitum.
The cage bedding was changed three times a week. The protocol
employed in this study was approved by the local Ethics Commit-
tee (number 08.1.1091.53.0).
2.4. Animal infection with S. mansoni
Mice were infected by subcutaneous injection with 1.0  102
cercariae of S. mansoni per animal.
2.5. Chemicals and experimental protocol
Mice were grouped into not infected, infected not treated and
infected treated (with either alkaloidic extract or PZQ) groups (Ta-
ble 1). Concerning to control groups, infected group without treat-
ment and group not infected received, by gavage, only 0.2 mL of
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injection with 1.0  102 cercariae on the 1st day.
Two groups of infected animals were treated with alkaloidic ex-
tract: one between 37th and 41st day after infection and the other
one between 45th and 49th day after infection. Both groups re-
ceived 10, 20 and 40 mg/kg of the extract daily by gavage. Another
infected group was treated daily by gavage only with PZQ (60 mg/
kg) between 45th and 49th day after infection. All animals were
euthanized on 55th day.
PZQ was administered only in the chronic phase of treatment
(after 45 days), since previous studies in the literature showed that
its action occurs only on adult worms causing its death by different
effects, such as paralysis and disruption of its teguments (Aragon
et al., 2009; Keiser et al., 2009). All the animals were euthanized
on the 55th day.
To investigate the possible immunomodulatory effect in ani-
mals not infected, groups of 5 animals were treated with 10, 20
and 40 mg/kg of the alkaloidic extract, respectively, daily for two
days using the protocol described by Benencia et al. (2000) with
adaptations.2.6. Number of macrophages
Macrophages were obtained from all the animal groups by
injection of 10 mL of RPMI 1640 medium (Cultlab) into the perito-
neal cavity. Four days before euthanasia, not infected control ani-
mals had been intraperitoneally stimulated with 3% thioglycolate
medium. After euthanasia, cells were centrifuged for 15 min, and
the pellet was re-suspended in RPMI 1640 medium, diluted with
Turkey solution (acetic acid, methylene blue, and gentian violet)
and counted in a Neubauer chamber, as described by Kuehn et al.
(2009).2.7. Measurement of NO production
NO production was measured as nitrite accumulated in the
supernatant, using the Griess reaction (nitrite is a stable break-
down product of NO). Cells were collected from the peritoneal cav-
ity of the mice, diluted in RPMI 1640 medium (Cultlabl), and
centrifuged for 15 min. The pellet was re-suspended in ice-cold
RPMI 1640 medium, and the cell concentration was adjusted to
5  106 cells/mL. Cell suspensions (100 lL) were plated into wells
of 96-well ﬂat-bottom culture plates (Coring) with or without
LPS (100 lg/mL). A previous pilot study had been conducted, toTable 1
In vivo experimental protocol.
Treatment: from 37th to 41st day post
infection
Group Dose/alkaloidic
extract
Not Infected I Untreated
Infected II Untreated
III 10 mg/kg
Infected IV 20 mg/kg
V 40 mg/kg
Treatment: from 45th to 49th day post
infection
Group Dose/alkaloidic
extract
Not Infected I Untreated
Infected II Untreated
III 10 mg/kg
Infected IV 20 mg/kg
IV 40 mg/kg
Treatment: from 45th to 49th day post
infection
Group Dose/praziquantel
Infected VI 60 mg/kgchoose the extract concentration that better stimulated mice cells.
The plates were incubated at 37 C, in 5% carbon dioxide (CO2), for
48 h. After this period, 100 lL of the supernatant was collected and
transferred to other 96-well ﬂat-bottom culture plates. The super-
natants were incubated with 100 lL of Griess reagent (50 lL of 1%
sulfanilamide (Sigma) plus 50 lL of 0.1% N-1-naphthylethylenedi-
amine (Sigma) in 5% phosphoric acid solution) at room tempera-
ture, for 5 min (Griess, 1879). The absorbance was measured at
540 nm, in triplicate, and compared with a sodium nitrite standard
curve. Data are expressed in lM.
2.8. Interferon-gamma (INF-c) assay
The serum INF-c levels were quantiﬁed using mouse INF-c/
DuoSet R&D Systems (Catalog Number DY485, Lot. 1153728). This
ELISA development kit contains the basic components for the
development of sandwich ELISA required to measure natural and
recombinant mouse INF-c.
2.9. Number of eggs
One piece of the liver taken from each mouse was weighed and
digested in KOH 4%, and the number of eggs was counted.
2.10. Histological observations
A small piece of the liver was ﬁxed in 10% formalin solution,
processed in parafﬁn blocks, sectioned (4-lm thick), stained with
hematoxylin and eosin (H&E), and examined with a Zeiss binocular
microscope (Carll Zeiss, Axiostar, Germany), 10 objective. Liver
egg granulomas were counted in twenty successive low-power
microscopic ﬁelds (10) of 6.4 mm2, and the granuloma density
was estimated by calculating the number of granulomas per/
mm2 of liver tissue section using graduated eyepiece (Zeiss) (Hurst
et al., 2000; Helmy et al., 2009).
2.11. Statistical analysis
Results are expressed as the mean ± SEM of the mean. Statistical
signiﬁcance between the groups was determined by two-way anal-
ysis of variance (ANOVA) post tests Bonferroni. All the statistical
analyses were undertaken using Graph Pad Prism version 5.0.
3. Results
3.1. Number of macrophages
The number of peritoneal macrophages was observed on 55th
day post-infection for all groups (Fig. 1). Animals treated with
20 mg/kg/day alkaloidic extract between 37th and 41st day after
infection, displayed higher number of macrophages compared with
the 40 mg/kg/day treated group (P < 0.01). Groups treated with 10
and 20 mg/kg/day showed a difference in comparison with in-
fected and not treated group (P < 0.001) (Fig. 1).
In the treatment between 45th and 49th day post-infection,
only animals treated with PZQ displayed greater number of macro-
phages in comparison with all other groups (P < 0.001) (Fig. 1).
3.2. Nitric oxide (NO)
We measured NO production in the mice using cells harvested
from the peritoneal cavity on the 55th day after infection. Groups
treated with 10 and 20 mg/kg/day furnished statistically different
results compared with mice belonging to infected and not treated
group (Fig. 2). Animals treated between 37th and 41st day after
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Fig. 1. Peritoneal macrophage counts on 55th day post infection. The values represent the mean ± SEM (n = 5). Between 37th and 41st: ⁄⁄⁄(P < 0.001) for infected not treated
vs 10 and 20 mg/kg; #(P < 0.01) for 10 mg/kg vs 40 mg/kg; (P < 0.01) for 20 mg/kg vs 40 mg/kg. Between 45th and 49th: ⁄⁄⁄(P < 0.001) for PZQ (60 mg/kg) vs infected not
treated and treated with 10, 20 and 40 mg/kg.
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icantly increased NO concentrations compared with the dose of
40 mg/kg/day (P < 0.01). Groups treated with 10 and 20 mg/kg/
day showed a signiﬁcant statistical difference in comparison with
infected and not treated group (Fig. 2). In the presence of the gran-
uloma (45th–49th days) mice treated with PZQ exhibited higher
NO values compared with all the other treatments (P < 0.001)
(Fig. 2).
3.3. Interferon-gamma production
Measurement of IFN-c production on the 55th day post-infec-
tion revealed elevated IFN-c concentrations for mice treated be-
tween 37th and 41th day post-infection for all doses as
compared with infected not treated group. Animals treated with
20 mg/kg/day displayed higher number of IFN-c production com-
pared with 40 mg/kg/day (P < 0.01). PZQ showed increasing values
compared with all other doses of treatments of the period between
45th and 49th day post-infection (P < 0.001) (Fig. 3).
3.4. Immunomodulatory effect of the alkaloidic extract
Mice belonging to groups of animals not infected and treated
with 10, 20, and 40 mg/kg of alkaloidic extract did not display sig-
niﬁcantly different number of macrophages, NO production, orI II III IV V I II
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Fig. 2. Nitric oxide production on 55th day post infection. The values represent the mean
⁄⁄(P < 0.01) infected not treated vs 20 mg/kg; #(P < 0.01) 20 mg/kg vs 40 mg/kg. Between
40 mg/kg.IFN-c levels compared with untreated and not infected control
group (data not shown).
3.5. Number of eggs
There was a reduction in the number of eggs in the liver of ani-
mals treated with different concentrations of alkaloidic extract. A
signiﬁcant result was found compared with control group for ani-
mals treated with 10 mg/kg (P < 0.05) and 20 mg/kg (P < 0.01) after
37th days of infection. However, we did not detect any statistical
differences for animals treated with 40 mg/kg in comparison with
control group (Fig. 4). On 45th day post-infection, animals treated
with 20 and 40 mg/kg of alkaloidic extract (P < 0.05) and 60 mg/kg
of PZQ displayed signiﬁcantly reduced number of eggs compared
with the control (P < 0.001).
3.6. Histological observations
The number of granulomas signiﬁcantly diminished in animals
treated with 10 and 20 mg/kg compared with infected control
groups on 37th day (P < 0.05) (Fig. 5). On 45th day, a reduction of
the number of granulomas was displayed compared with control
group for all drug concentrations. Mice treated with PZQ also pre-
sented signiﬁcantly lower number of granulomas compared with
the infected control group (P < 0.01).III IV V
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VI
± SEM (n = 5). Between 37th and 41st: ⁄(P < 0.05) infected not treated vs 10 mg/kg;
45th and 49th: ⁄⁄⁄(P < 0.001) PZQ (60 mg/kg) vs infected not treated and 10, 20 and
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Fig. 3. IFN-c assay on 55th day post infection. The values represent the mean ± SEM
(n = 5). Between 37th and 41st: ⁄⁄(P < 0.01) infected not treated vs 10, 20 mg/kg;
#(P < 0.01) 20 mg/kg vs 40 mg/kg. Between 45th and 49th: ⁄⁄⁄(P < 0.001) PZQ
(60 mg/kg) vs infected not treated and 10, 20 and 40 mg/kg.
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Fig. 4. Number of eggs in mice infected on 55th day post infection. The values
represent the mean ± SEM (n = 5). Between 37th and 41st: ⁄(P < 0.05) infected not
treated vs 10 mg/day; ⁄⁄(P < 0.01) infected not treated vs 20 mg/kg. Between 45th
and 49th: ⁄(P < 0.05) infected not treated vs 20 and 40 mg/kg. ⁄⁄⁄(P < 0.001) PZQ vs
infected not treated and 10, 20 and 40 mg/kg.
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The widespread reliance on PZQ to control schistosomiasis may
hasten the selection of drug-resistant parasites. Fallon and Doen-
hoff (1994) identiﬁed PZQ-resistant isolates of S. mansoni and se-
lected PZQ-resistant parasites in the laboratory by six or seven
drug-treated passages of S. mansoni in mice. Praziquantel has been
found to be less effective for patients repeatedly treated for schis-
tosomiasis in Kenya. Although this phenomenon is not signiﬁcantI II III IV I II III IV
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Fig. 5. Numbers of granulomas per mm2 of liver on 55th day post infection. The
values represent the mean ± SEM (n = 5). Between 37th and 41st: ⁄(P < 0.05)
infected not treated vs 10 and 20 mg/kg. Between 45th and 49th: ⁄(P < 0.05)
infected not treated vs 10, 20 and 40 mg/kg; ⁄⁄(P < 0.01) infected not treated vs PZQ.enough to pose a clinical problem in the short term, it should be
taken into account if one wishes to avoid drug resistance (Melman
et al., 2009). In countries like Egypt, an increasing number of pa-
tients have displayed resistance to treatment with PZQ, which
was not only due to resistance by the S. mansoni strain resistance,
but also to host factors, such as immune system response to the
infection (Ismail et al., 1999). Therefore, in the absence of an ade-
quate vaccine to prevent S. mansoni infection and in the face of
drug-resistant strains, a joint effort toward the discovery of new
antiparasitic agents to treat schistosomiasis is mandatory.
In this work, our ﬁrst step was to verify the actions of alkaloidic
extract in the induction of macrophages proliferation. We found
that this extract acted on the cellular immune response of mice in-
fected with S. mansoni – we detected a signiﬁcantly elevated num-
ber of these cells in mice treated with all the tested doses of the
extract after 37 days of infection, especially for the daily dose of
20 mg/kg.
It is well established that macrophages participate as a ﬁrst line
defense cell against pathogens. Macrophages, together with cyto-
kines type Th1, control ﬁbrosis during S. mansoni infection,
although the mechanism through which macrophages kill schisto-
somes remains uncertain (Hesse et al., 2001; James, 1986).
Activatedmacrophages are essential for host survival during the
chronic phase of S. mansoni infection; and in their absence, the egg-
induced inﬂammatory response is lethal (Herbert et al., 2004). The
kind of macrophage activation during S. mansoni infection is also
important. Bone marrowmyeloid progenitor cells differentiate into
monocytes in the presence of cytokines such as macrophage col-
ony-stimulating factor (M-CSF), granulocyte/macrophage colony-
stimulating factor (GM-CSF), IL-3, and TNF-a (Kondo et al., 2000).
Our results show that therapy with the alkaloidic extract of S. lyco-
carpum fruits enhanced the number of macrophages, thereby
diminishing the damage in the hepatic tissue of hosts infected with
S. mansoni.
The role of NO acts as an effector molecule during schistosomi-
asis. Different researchers showed that inhibition of inducible ni-
tric oxide synthase (iNOS) is detrimental to infected animals
mainly when the liver ﬁrst becomes exposed to parasite eggs.
The absence of NO can lead to severe hepatic damage and in-
creased morbidity. Therefore, effective production of Th1 cyto-
kines, including NO, avoids hepatocyte damage and ﬁbrosis
caused by the arrival of eggs in the liver. An important function
of NO against hepatic ﬁbrosis is to trigger the effective production
of Th1 cytokines, which prevents the hepatocyte damage caused by
arrival of eggs in the liver (Hesse et al., 2001; Grzych et al., 1991).
Many investigations have assayed the true action of NO in the
immune response, but papers have produced conﬂicting results.
NO can display either cytoprotective or cytotoxic effects, depend-
ing on the conditions; for instance, the factors involved in the ini-
tial injury (Bogdan, 1998; Fang, 1997; Brune et al., 1995). Its
balance along with some inﬂammatory cytokines and mediators,
such as TNF-a, IL-1b, and IFN-c, is crucial when determining the
deleterious effects of the disease in the host.
The mice treated with the alkaloidic extract of S. lycocarpum
fruits at a concentration of 20 mg/kg on the 37th day after infection
displayed increased NO and IFN-c production. PZQ also raised the
concentration of these cytokines on the 45th day post-infection,
which corresponds to the chronic phase of S. mansoni infection.
Several human and mice assays have suggested that an imbal-
ance in the Th1 immune response is involved in the pathogenesis
of hepatic ﬁbrosis (Mwatha et al., 1998; Adewusi et al., 1996). Che-
ever et al. (2000) reported that a Th2 response also contributed to
chronic morbidity. It seems that a speciﬁc interleukin is involved in
this process, being IL-13 the main cytokine responsible for the
induction of ﬁbrosis. Some other papers described that IFN-c pro-
duction during S. mansoni infection is important to prevent the re-
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ﬁbrosis in the liver during the chronic phase of schistosomiasis
(Montesano et al., 1997). Cytokines like IFN-c and NO are probably
directly linked to the balance of IL-13-mediated ﬁbrosis (Hesse
et al., 2001; Montenegro et al., 1999).
Following administration of the alkaloidic extract on the 37th
day and PZQ on the 45th day post-infection, we found that the high
IFN-c and NO production during S. mansoni infection happens con-
comitantly with a statistically signiﬁcant decrease of the egg bur-
den and granuloma formation in the liver. Hence, alternative
therapies based on solasonine and solamargine compounds, which
correspond to more than 80% of the alkaloidic extract, could be
proposed (Tiossi et al., 2012).
The alkaloidic extract of S. lycocarpum fruits inhibited egg pro-
duction during the chronic phase of the disease. This is an impor-
tant result, because the main laboratory diagnosis for this illness is
the presence of eggs; eggs are considered to be mainly responsible
for cellular immunological imbalances, such as impaired macro-
phages and cytokines production.
Several factors are involved in the protection that cytokines
confer to animals infected with S. mansoni. Some papers have de-
scribed a direct action against adult worms (Kim et al., 1997), in
which NO plays a protective role in preventing hepatocyte apopto-
sis (Bohlinger et al., 1995). On the other hand, enhanced IFN-c lev-
els induce NO production infection (Joseph and Boros, 1993;
Mccormick et al., 1996). In addition, reactive oxygen species can
mediate NO protection against cellular damage (Wink et al., 1993).
The number of adult worms (males, females, and couples)
recovered by perfusion of the hepatic portal system on the 55th
day post-infection was not statistically different (P > 0.05) when
mice treated with PZQ were compared with infected, not treated
animals (data not shown in this paper). This can be partly ex-
plained by the fact that the technique used to recover worms (per-
fusion) is difﬁcult to performworms can be lost in the abdominal
cavity, making their accurate quantiﬁcation difﬁcult.
We had already veriﬁed the in vitro activity of the alkaloidic ex-
tract of S. lycocarpum fruits against S. mansoni adult (Miranda et al.,
2012), but it should be noted that the bioavailability (absorption)
of the alkaloids present in this extract may be hampered upon oral
administration. These compounds bear sugar units, so their bio-
availability may also decrease because the gut microbiota of ani-
mals may metabolize them. Therefore, other routes of
administration should be tested. However, pharmaceutical formu-
lations should also be developed, so as to increase their bioavail-
ability by oral route.
Further studies should be undertaken, to better explore the im-
mune mechanisms taking place during S. mansoni infection. The
use of the alkaloidic extract of S. lycocarpum can be useful to inves-
tigate its actions on the host’s immune response, which shall pro-
vide new perspectives for an alternative control of parasite and
granuloma development during the course of schistosomiasis.
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